Advanced search
1 file | 523.59 KB

SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013)

David Creytens (UGent) and Liesbeth Ferdinande (UGent)
(2015) HISTOPATHOLOGY. 67(2). p.272-273
Author
Organization
Keywords
TELANGIECTATIC OSTEOSARCOMA

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 523.59 KB

Citation

Please use this url to cite or link to this publication:

Chicago
CREYTENS, DAVID, and Liesbeth Ferdinande. 2015. “SATB2 Is a Novel Marker of Osteoblastic Differentiation in Bone and Soft Tissue Tumours: Comment on Conner Et Al. (2013).” Histopathology 67 (2): 272–273.
APA
CREYTENS, D., & Ferdinande, L. (2015). SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013). HISTOPATHOLOGY, 67(2), 272–273.
Vancouver
1.
CREYTENS D, Ferdinande L. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013). HISTOPATHOLOGY. 2015;67(2):272–3.
MLA
CREYTENS, DAVID, and Liesbeth Ferdinande. “SATB2 Is a Novel Marker of Osteoblastic Differentiation in Bone and Soft Tissue Tumours: Comment on Conner Et Al. (2013).” HISTOPATHOLOGY 67.2 (2015): 272–273. Print.
@article{5933731,
  author       = {Creytens, David and Ferdinande, Liesbeth},
  issn         = {0309-0167},
  journal      = {HISTOPATHOLOGY},
  language     = {eng},
  number       = {2},
  pages        = {272--273},
  title        = {SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013)},
  url          = {http://dx.doi.org/10.1111/his.12628},
  volume       = {67},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: